series-c-plus
Stage
1
Investors
About
Tourmaline Bio develops diagnostic tests that use circulating tumor DNA for early detection and risk assessment of cancer.
Explore Tourmaline Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.